Figures & data
Figure 1 Structure of the model.
Copyright © 1998, Adis International. Schädlich PK, Brecht JG. The cost effectiveness of acamprosate in the treatment of alcoholism in Germany. Economic evaluation of the Prevention of Relapse with acamprosate in the Management of Alcoholism (PRAMA) Study. Pharmacoeconomics. 1998;13:719–730.Citation2
Table 1 Abstained and relapsed patients
Table 2 DRG costs for alcohol-related diseases/rehabilitation costs for alcohol-related diseases
Table 3 Number of alcohol-related complications (ICD) for patients from SerT clinics and for patients discharged from hospital
Figure 2 Total cost (hospital, rehabilitation, drugs) for SerT patients in the different treatment strategies.
Figure 3 Total cost (hospital, rehabilitation, drugs) for hospital-discharged patients in the different treatment strategies.
Table 4 Results of the budget impact analysis
Figure 4 Budget impact analysis results: simulation of potential saving (10-year time horizon).
